Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    ARD12130
Show Display Options
Rank Status Study
1 Completed A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Condition: Lymphoma
Intervention: Drug: SAR245409

Indicates status has not been verified in more than two years